BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15154339)

  • 1. Switzerland's medical technology potential.
    Med Device Technol; 2004 Mar; 15(2):41-2. PubMed ID: 15154339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotech parks proliferate, despite concerns over sustainability.
    Jia H; Jayaraman KS; Orellana C
    Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
    [No Abstract]   [Full Text] [Related]  

  • 3. Benefits of biotech clusters questioned.
    Sheridan C
    Nat Biotechnol; 2003 Nov; 21(11):1258-9. PubMed ID: 14595343
    [No Abstract]   [Full Text] [Related]  

  • 4. First U.S.-Russian business venture in closed nuclear city.
    Lopatto J; Wilkes B
    Health Phys; 2004 Feb; 86(2):212-3. PubMed ID: 14744060
    [No Abstract]   [Full Text] [Related]  

  • 5. A dynamic industry where innovation is a priority.
    Med Device Technol; 2005 Oct; 16(8):38-42. PubMed ID: 16355971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Business opportunities abound in Israel.
    Nir MM; Rotem-Bar J
    Med Device Technol; 2002 Oct; 13(8):43-4. PubMed ID: 12416334
    [No Abstract]   [Full Text] [Related]  

  • 7. France to focus on a few biotech clusters.
    Balcon E
    Nat Biotechnol; 2004 Sep; 22(9):1063-4. PubMed ID: 15340457
    [No Abstract]   [Full Text] [Related]  

  • 8. More than the sum of their parts? Clustering is becoming more prevalent in the biosciences, despite concerns over the sustainability and economic effectiveness of science parks and hubs.
    Rinaldi A
    EMBO Rep; 2006 Feb; 7(2):133-6. PubMed ID: 16452923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The industry in Europe: more together than apart.
    Med Device Technol; 2005 Nov; 16(9):32, 34, 36-7. PubMed ID: 16438447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domestic device consumption up 7% in '93--HIMA report.
    Scott L
    Mod Healthc; 1994 Jan; 24(3):16. PubMed ID: 10131119
    [No Abstract]   [Full Text] [Related]  

  • 11. Ireland: positively influencing progress.
    Carroll S
    Med Device Technol; 2001 Nov; 12(9):38-9. PubMed ID: 12938538
    [No Abstract]   [Full Text] [Related]  

  • 12. US NHGRI launches chemical attack on drug development gap.
    Garber K
    Nat Biotechnol; 2003 Nov; 21(11):1253-4. PubMed ID: 14595338
    [No Abstract]   [Full Text] [Related]  

  • 13. [Medical equipment companies and their ties with technology development centers in Mexico].
    Hernández B; Arredondo A; Cruz C; Sánchez E; Damián T
    Bol Oficina Sanit Panam; 1993 Oct; 115(4):317-27. PubMed ID: 8240702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The year in preview: government sees device industry up with economy.
    Med Prod Sales; 1984 Feb; 15(2):56-9. PubMed ID: 10265463
    [No Abstract]   [Full Text] [Related]  

  • 15. India aims to become the main bioinformatics hub.
    Jayaraman KS; Louët S
    Nat Biotechnol; 2004 Aug; 22(8):933. PubMed ID: 15286632
    [No Abstract]   [Full Text] [Related]  

  • 16. Chinese biotech: the need for innovation and higher standards.
    Wong GH
    Nat Biotechnol; 2006 Feb; 24(2):221-2. PubMed ID: 16465169
    [No Abstract]   [Full Text] [Related]  

  • 17. Ireland: delivering today and tomorrow.
    Med Device Technol; 2007 Oct; 18(6):43. PubMed ID: 18078182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NHS needs innovation, not patient care on-the-cheap.
    Wilkinson J
    Med Device Technol; 2005 Dec; 16(10):43. PubMed ID: 16419928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Japan launches new life-science initiatives.
    Triendl R
    Nat Biotechnol; 2003 Mar; 21(3):218. PubMed ID: 12610556
    [No Abstract]   [Full Text] [Related]  

  • 20. Denmark in focus.
    Med Device Technol; 2004; 15(1):74. PubMed ID: 14994640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.